276 related articles for article (PubMed ID: 16227327)
1. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.
Sin DD; Wu L; Anderson JA; Anthonisen NR; Buist AS; Burge PS; Calverley PM; Connett JE; Lindmark B; Pauwels RA; Postma DS; Soriano JB; Szafranski W; Vestbo J
Thorax; 2005 Dec; 60(12):992-7. PubMed ID: 16227327
[TBL] [Abstract][Full Text] [Related]
2. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity.
Sin DD; Golmohammadi K; Jacobs P
Am J Med; 2004 Mar; 116(5):325-31. PubMed ID: 14984818
[TBL] [Abstract][Full Text] [Related]
4. Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients?
Sin DD; Man SF
Curr Opin Pulm Med; 2007 Mar; 13(2):90-7. PubMed ID: 17255798
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
6. Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study.
van der Valk P; Monninkhof E; van der Palen J; Zielhuis G; van Herwaarden C
Am J Respir Crit Care Med; 2002 Nov; 166(10):1358-63. PubMed ID: 12406823
[TBL] [Abstract][Full Text] [Related]
7. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
8. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
Gershon AS; Wang L; To T; Luo J; Upshur RE
COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
[TBL] [Abstract][Full Text] [Related]
9. [Do inhaled corticosteroids reduce mortality in chronic obstructive pulmonary disease?].
Bridevaux PO; Leuenberger P
Rev Med Suisse; 2005 Nov; 1(41):2673-4, 2677-9. PubMed ID: 16355882
[TBL] [Abstract][Full Text] [Related]
10. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
Tashkin DP
Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
[TBL] [Abstract][Full Text] [Related]
11. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis.
Fan VS; Bryson CL; Curtis JR; Fihn SD; Bridevaux PO; McDonell MB; Au DH
Am J Respir Crit Care Med; 2003 Dec; 168(12):1488-94. PubMed ID: 14525798
[TBL] [Abstract][Full Text] [Related]
12. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.
Singh S; Amin AV; Loke YK
Arch Intern Med; 2009 Feb; 169(3):219-29. PubMed ID: 19204211
[TBL] [Abstract][Full Text] [Related]
13. Do inhaled corticosteroids slow FEV1 decline in COPD after all?
Duerden MG
Thorax; 2004 Jun; 59(6):538-9; author reply 539-40. PubMed ID: 15170045
[No Abstract] [Full Text] [Related]
14. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
Zietkowski Z; Kucharewicz I; Bodzenta-Lukaszyk A
Respir Med; 2005 Jul; 99(7):816-24. PubMed ID: 15939243
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.
Gagnon YM; Levy AR; Spencer MD; Hurley JS; Frost FJ; Mapel DW; Briggs AH
Respir Med; 2005 Dec; 99(12):1534-45. PubMed ID: 16291076
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy for mortality reduction in chronic obstructive pulmonary disease.
Sin DD; Man SF
Proc Am Thorac Soc; 2006 Sep; 3(7):624-9. PubMed ID: 16963545
[TBL] [Abstract][Full Text] [Related]
17. Alveolar-capillary membrane permeability for early prediction of response of inhaled steroid on patients with chronic obstructive pulmonary disease.
Chou SH; Chen YW; Chuang HY; Kao EL; Huang MF
J Clin Pharm Ther; 2006 Aug; 31(4):363-8. PubMed ID: 16882106
[TBL] [Abstract][Full Text] [Related]
18. Steroid therapy in chronic obstructive pulmonary disease.
OBrien A; Ward NS
Med Health R I; 2002 Feb; 85(2):52-5. PubMed ID: 11881166
[TBL] [Abstract][Full Text] [Related]
19. Ethics of placebo controlled studies of inhaled steroids for COPD.
Hahn DL
Thorax; 2004 Jun; 59(6):539; author reply 539-40. PubMed ID: 15170046
[No Abstract] [Full Text] [Related]
20. A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo.
Soriano JB; Sin DD; Zhang X; Camp PG; Anderson JA; Anthonisen NR; Buist AS; Burge PS; Calverley PM; Connett JE; Petersson S; Postma DS; Szafranski W; Vestbo J
Chest; 2007 Mar; 131(3):682-689. PubMed ID: 17356080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
